NEW YORK, May 18, 2017 -- Nine discussion panels on strategic topics of special relevance to the microcap market will be offered at the 2017 Marcum MicroCap Conference, taking place June 15-16 at the Grand Hyatt Hotel in New York City. More than 2,000 participants from all segments of the microcap market attend the event each year.
This year’s panel topics are as follows:
Thursday, June 15
- Uplisting to an Exchange: What Every Company Needs to Know Before, During and After Listing – moderated by Andrew Hall, Managing Director, New Listings, NASDAQ
- Chinese Investment in the United States: Venture, M&A, and EB-5 Capital – moderated by Drew Bernstein, Co- Managing Partner, Marcum Bernstein Pinchuk
- Best Practices in Corporate Governance, Legal and Accounting Matters: Key Issues and Hot Topics that Matter to Investors and Regulators – moderated by Caryn Schechtman, Partner, DLA Piper
- Up in Smoke? How to Invest in the Cannabis Industry: Identifying Opportunities, Financial and Legal Hurdles, and the Outlook for the Cannabis Industry under the new Administration – moderated by Marc Ross, Partner, Sichnezia Ross Ference Kesner LLP
- Using Tax Credits as a Planning Tool – moderated by Melina Ambrosino, Executive Vice President, Cherrytree Group
- Identifying Breakthrough Opportunities in Life Sciences: How to Evaluate Early Stage and Pre-Revenue Life Sciences Companies – moderated by Jim Alfaro, Co-Head of Healthcare Investment Banking, Maxim Group LLC
Friday, June 16
- Regulation A+: Two Years After the Creation of the “The Mini IPO” – moderated by Mitchell Littman, Founding Partner, Littman Krooks LLP
- The Current Environment for Capital-Raising: Funding Options and Structures Geared towards Microcap Companies – moderated by Alexander McClean, Partner, Harter Secrest & Emery LLP
- How Liquidity Impacts the Value of a Microcap Stock: How to Identify Companies that are Effectively Building an Active and Diverse Shareholder Base and Techniques to Achieve those Results – moderated by Jeffrey Goldberger, Managing Partner, KCSA
David Bukzin, partner-in-charge of Marcum’s SEC Services Practice group and chair of the event, said, “Every year, we are privileged to assemble presenters from different segments of the microcap industry to discuss some of the most pressing topics facing pre-IPO and publicly traded companies, and the various constituencies that have an interest in this marketplace. All conference participants, from every segment of the microcap market, will benefit from the fresh thinking and diverse perspectives of our panelists.”
Visit www.marcummicrocap.com for a complete schedule of conference panels.
The Marcum MicroCap Conference is presented by Marcum LLP, a top national accounting and advisory firm with offices in major business markets throughout the U.S., as well as Grand Cayman, China and Ireland. Since its launch in 2012, this event has become a nationally recognized forum for publicly traded companies with less than $500 million in market capitalization to network with fund managers and high net worth investors who focus on small cap equities. Attendees include senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace. For registration and sponsorship information, visit www.marcummicrocap.com.
Marcum is a registered Public Company Accounting Oversight Board (PCAOB) firm. Marcum's Assurance Division provides the most up-to-date service and guidance on SEC accounting and reporting issues. Services include Financial Statement Audits in accordance with PCAOB standards; Tax Compliance and Advisory Services; Due Diligence; Agreed-Upon Procedures and Other Attest Work; Internal Audit Services; Sarbanes-Oxley Section 404 Compliance Services and Software; Technical Accounting Assistance; and IPO Assistance. For more information, visit www.marcumllp.com.
About Marcum
Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation, with offices in major business markets throughout the U.S., as well as Grand Cayman, China and Ireland. Headquartered in New York City, Marcum provides a full spectrum of traditional tax, accounting and assurance services; advisory, valuation and litigation support; and an extensive range of specialty and niche industry practices. The Firm serves both privately held and publicly traded companies, as well as high net worth individuals, private equity funds and hedge funds, with a focus on middle-market companies and closely held family businesses. Marcum is a member of the Marcum Group, an organization providing a comprehensive array of professional services. For more information, visit www.marcumllp.com.
Julie Gross Gelfand, APR [email protected] (631) 414-4302


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Washington Post Publisher Will Lewis Steps Down After Layoffs
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 



